Literature DB >> 1932577

Fine needle aspiration cytology and immunocytochemistry of metastatic melanoma.

K Nasiell1, E Tani, L Skoog.   

Abstract

The cytological and immunological findings of 81 metastatic melanomas are described. Fine needle aspiration was performed from secondary deposits in lymph nodes (38), subcutaneous and soft tissue (36), abdomen (5), lung (1) from 67 patients with histologically verified malignant melanoma. One patient had disease which had spread into the cerebrospinal fluid. Cytomorphologically the cases were classified as classical (47%), carcinoma-like (22%), spindle cell type (14%), lymphoma like (6%), undifferentiated (6%), myxoid type (3%), and clear cell type (2%). All cases were immunologically characterized using antibodies to S-100, vimentin and cytokeratin. All cases were S-100 positive and the majority (96%) reacted with antibodies to vimentin. A weak heterogenous reactivity to cytokeratin antibody was detected in only eight cases. The HMB45 antibody was applied to 20 cases and 16 (80%) of these tumours were positive. In summary, we found that an immunological characterization was necessary to conclusively diagnose over 50% of metastatic melanomas which presented with an equivocal cytological picture.

Entities:  

Mesh:

Year:  1991        PMID: 1932577     DOI: 10.1111/j.1365-2303.1991.tb00398.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  7 in total

Review 1.  Fine needle aspiration of lymph nodes.

Authors:  I D Buley
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

2.  HMB45: a specific marker for melanoma metastases in the central nervous system?

Authors:  K Schwechheimer; L Zhou
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  FNA diagnosis of malignant melanoma-recurrent and metastatic disease.

Authors:  Kiran Alam; Anshu Jain; Meher Aziz; Aroonima Misra
Journal:  BMJ Case Rep       Date:  2012-11-14

4.  Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma.

Authors:  Gulsun Erdag; Sinchita Roy Chowdhuri; Patricia Fetsch; Dana Erickson; Marybeth S Hughes; Armando C Filie
Journal:  Diagn Cytopathol       Date:  2013-04-03       Impact factor: 1.582

Review 5.  Cytologic diagnosis of metastatic melanoma by FNA: A practical review.

Authors:  Andrea Ronchi; Marco Montella; Federica Zito Marino; Giuseppe Argenziano; Elvira Moscarella; Gabriella Brancaccio; Giuseppe Ferraro; Giovanni Francesco Nicoletti; Teresa Troiani; Renato Franco; Immacolata Cozzolino
Journal:  Cancer Cytopathol       Date:  2021-07-26       Impact factor: 4.264

6.  Diagnostic accuracy of fine needle biopsy for metastatic melanoma and its implications for patient management.

Authors:  Anna Doubrovsky; Richard A Scolyer; Rajmohan Murali; Paul R McKenzie; Geoffrey F Watson; C Soon Lee; Duncan J McLeod; William H McCarthy; Roger F Uren; Jonathan R Stretch; Robyn P Saw; John F Thompson
Journal:  Ann Surg Oncol       Date:  2007-11-08       Impact factor: 5.344

7.  Amelanotic Melanoma Presenting with Plasmacytoid Morphology and BRAF V600 Mutation.

Authors:  Linda Kocovski; Anita Bane; Shangguo Tang; Samih Salama; Salem Alowami
Journal:  Rare Tumors       Date:  2015-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.